Measurable Disease
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy of Venetoclax Based Regimen in Prevention Relapse of Consecutive MRD Positive AML Patients (NCT05361057) | Institute of Hematology & Blood Diseases Hospital, China | 2022-06-29 |
| Pazopanib in Advanced and Cisplatin-resistant Germ Cell Tumors (NCT01743482) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2013-05-17 |
Track Measurable Disease automatically
Every clearance here is in the API, with alerts when new ones post.